Mammalian Cells Segment Held Largest Share of Europe Bioreactor Market in 2019
According to ournew market research study on “Europe Bioreactors Marketto 2027 – Regional Analysis and Forecast – by Cell, Molecule, Technology,and End User,”marketis expected to reach US$ 1,512.45 Mn by 2027 from US$ 885.26 Mn in 2019;it is estimated to grow at a CAGR of 7.0% from 2020 to 2027. The report provides trends prevailing in the Europebioreactors market as well as the factors driving market growth along with those hindering it.
The Europebioreactors market, based on the cell, is segmented into mammalian cells, bacterial cells, yeast cells,and others.The mammalian cellssegment held the largest share of the market in 2019, and the yeast cell segment is estimated to register the highest CAGR in the market during the forecast period. The projected growth of the market for yeast cellsis attributed to escalated use of these cells in single culture or along with other probiotic strains in probiotic production. Moreover, increasing research activities for industrial-scale production of probiotic yeasts would also boost the market growth in the coming years.
The growth of the Europebioreactors marketis mainly attributed to the increasing adoption of single-use bioreactors, and rapidly growing demand for bioreactors from biopharmaceutical and biotechnology industries. However, stringent regulatory framework is the major factor hindering the market growth in the region.
A few of the leading companies operating in the Europebioreactors market are Sartorius AG, Cellexus, bbi-biotech GmbH, GEA Group, Applikon Biotechnology BV,and MERCK KGaA.
Europe Bioreactors Market, By Country, 2019 (%)
Europe Bioreactors Market to Grow at a CAGR of 7.0% to reach US$ 1,512.45 Mn from 2020 to 2027
Download Free Sample
Europe Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)]– Regional Analysis and
Europe Bioreactors Market to Grow at a CAGR of 7.0% to reach US$ 1,512.45 Mn from 2020 to 2027
Download Free SampleEurope Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)]– Regional Analysis and
The report segments Europebioreactors market as follows:
Europe Bioreactors Market– ByCell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Others
Europe Bioreactors Market– ByMolecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
- Others
Europe Bioreactors Market – ByTechnology
- Wave-Induced Motion SUB
- Stirred SUB
- Single-Use Bubble Column
- Others
Europe Bioreactors Market – By End-users
- Biopharma Manufacturers
- Research and Development Organizations
- Contract Manufacturing Organizations (CMOs)
Europe Bioreactors Market– By Country
- Germany
- UK
- France
- Italy
- Spain
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com